Resveratrol exhibited reprogramming of EMT into MET in pancreatic cancer via suppression of AKT signaling pathways [104] and prevented EGF-mediated activation of EMT in the ER-positive breast cancer cell line (MCF-7) through suppression of the EGF-activated Erk pathway [105]. Here, EGF is linked to pancreatic neoplasm.